研究業績
-
2024年01月19日南川 特定研究員、日本免疫学会でベストプレゼンテーション賞受賞！
-
2024年01月04日Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells
-
2024年01月04日Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity.
-
2024年01月04日Differentiation of BCMA-specific induced pluripotent stem cells into CD8αβ+ T cellstargeting multiple myeloma.
-
2024年01月04日Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells.
-
2024年01月04日Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells
-
2024年01月04日人工胸腺オルガノイドからのCAR-T細胞の分化
-
2024年01月04日Basic research and clinical development of regenerative immunotherapy using iPS cells.
-
2024年01月04日Improved anti-solid tumor response by humanized anti-podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model.
-
2024年01月04日Successful organoid-mediated generation of iPSC-derived CAR-T cells
-
2024年01月04日Sustainable antiviral efficacy of rejuvenated HIV-specific cytotoxic T lymphocytes generated from induced pluripotent stem cells.
-
2024年01月04日iPS細胞のがん免疫療法への応用
